Will targeted treatment for gastric cancer turning into liver cancer cause hair loss?

If patients with advanced liver cancer take targeted drug therapy, the effect of targeted drugs will be greatly reduced in about a year. Active treatment alternatives can usually extend life by 1-3 years. If the molecular targeted node is positive, targeted therapy is required, which can effectively control the early stages of the disease, especially in reducing mass, but the disadvantage is that it is relatively expensive, so comprehensive treatment is required. Some targeted drug treatments can cause hair loss in patients.

Can liver transplantation be performed for advanced liver cancer?

If conditions permit, the liver can be changed for advanced liver cancer, but even if the conditions are determined, the patient will not survive very long, mainly because the patient's physical condition is very poor and the surgical trauma further damages the body. This treatment method is generally not used for patients with clinically advanced liver cancer. It is mainly symptomatic supportive treatment to delay life as much as possible. Liver cancer is a malignant tumor disease. If liver cancer has reached the late stage and the liver cannot be changed for treatment, there is not much meaning in changing the liver at this time. Patients can only improve their quality of life through radiotherapy and chemotherapy, and usually eat more nutritious foods to strengthen their physical fitness. There is no benefit in changing the liver for patients with advanced liver cancer, because patients with advanced liver cancer will have anemia, hypoproteinemia, and abnormal liver function, which manifests as a state of consumption of malignant diseases. They are also prone to complications of selective organ metastasis, which is an absolute contraindication for liver transplantation.

How long can you live with liver cancer metastasis?

Even if some patients have liver metastasis, they can live for 3-5 years after active and effective treatment. For example, patients with colorectal cancer liver metastasis can have some liver metastatic lesions surgically removed and chemotherapy after surgery, and their survival time is relatively long. Liver cancer is a common malignant tumor in the digestive system. If it can be detected early, about 15% of patients can survive for more than 5 years through radical surgical resection. The specific situation of the patient is still unclear, depending on factors such as the patient's current physical fitness, pathological stage, malignancy of cancer cells, and treatment effect.